Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,293,959
-$6,180,116 QoQ
Shares Held
187,110
-37.7% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#85
of 314 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. XENE ranks #47 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in XENE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,293,959 | 187,110 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $17,474,075 | 300,500 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $208,780 | 5,200 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $269,180 | 8,600 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,190,185 | 154,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $537,040 | 13,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,732,280 | 44,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,622,171 | 92,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,428,020 | 56,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,501,556 | 32,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $748,104 | 21,900 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $4,609,252 | 150,777 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,898,597 | 380,877 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,459,496 | 619,077 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,251,531 | 657,977 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,404,288 | 692,977 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $11,842,246 | 769,977 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,999,276 | 903,277 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,982,373 | 1,035,277 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,936,793 | 788,077 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||